Journament Logo
  • Home
  • Statistics
  • How It Works
  • Login
  • Register
Keyword Connections - alemtuzumab Keywords
Connection Type Connection
Journals
Journal of speech, language, and hearing research : JSLHR
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Research Groups
No Research Group Connected
Bibliographies
[1] understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the alemtuzumab clinical development program
[2] repopulation of t, b, and nk cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis
[3] Sensitizing the interdisciplinary team to desensitizations: An alemtuzumab case report.
[4] comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis
[5] understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the alemtuzumab clinical development program
[6] repopulation of t, b, and nk cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis
[7] Pentostatin, Cyclophosphamide and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-ACRIN Cancer Research Group (E2903)
Journament

Journament is a unique journals indexing service that helps researchers find the perfect publication venue for their work.

Quick Links
  • Home
  • Statistics
  • How It Works
  • Login
  • Register
Resources
  • Blog
  • Help Center
  • FAQs
  • Contact Us
Partner Sites
  • SciMatic
  • Semester Manager
  • Thesis Manager
  • TeamPo
  • ImProofer
Legal
  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • GDPR

© 2025 Journament. All rights reserved.